PhD in Chemistry: Targeting Hard-to-Treat Cancers with Metal-Organic Frameworks
Bright, highly motivated candidates are invited to apply for a fully funded 3.5 year PhD position in the School of Chemistry, available to commence on 1st October 2019 in the Forgan research group at the University of Glasgow, which is aligned with the £10M EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers:
The PhD project will investigate the synthesis and surface functionalisation of metal-organic framework nanoparticles (NMOFs), and their application in targeted delivery of therapeutics to fight cancer. The project will require synthesis and characterization of nanoparticulate MOFs, as well as a significant biological component.
The ideal candidate will hold (or expect to hold) a 1st or upper 2nd class MSc / MChem / BSc or equivalent, and have experience of organic and inorganic synthesis, solid-state analytical techniques, and cell biology. The student can expect to become an expert in the design, synthesis and analysis of porous materials, through hands on experience of solid-state synthesis, crystallographic techniques, NMR spectroscopy and gas uptake measurement, as well as being heavily involved in cell culture, imaging, and in vitro assays.
The research lies at the crossroads of synthetic inorganic chemistry, nanotechnology and biology, and the multidisciplinary nature of the work will require a student capable of administering collaborations, with associated opportunities for travel. More information on the Forgan group can be found at:
Prospective candidates should contact Dr Forgan for information by email – [Email Address Removed] – with a CV and cover letter, as soon as possible. Applications will be assessed on a rolling basis.
Funding is available to cover tuition fees for UK/EU applicants, as well as paying a stipend at the Research Council rate (estimated £14,999 for Session 2019-20).
Full funding (including payment of tuition fees) is only available to candidates from within the EU. Self-funded students from outside the EU are encouraged to contact Dr Forgan directly.